OxTalks will soon be transitioning to Oxford Events (full details are available on the Staff Gateway). A two-week publishing freeze is expected in early Hilary to allow all events to be migrated to the new platform. During this period, you will not be able to submit or edit events on OxTalks. The exact freeze dates will be confirmed as soon as possible.
If you have any questions, please contact halo@digital.ox.ac.uk
The University of Oxford will be hosting a virtual AIMday in Translational Dementia Research on 30 May 2022 as part of the conference “21st Century Translational Dementia Research” that will bring together industry and academia to discuss key challenges. The AIMday format allows industry to propose challenges for one-hour roundtable discussions with groups of relevant academics and clinicians from Oxford. This is a great chance to see how your research can be applied in industry and to meet potential future collaborators.
Participating companies include: Akrivia Health, Ainostics, BrainBerry Ltd, Cumulus Neuroscience, Cytox, NeuroBio Ltd, Novo Nordisk, Olink, PharmaKure and Stratastem
If you would also like to attend the conference please register at: www.eventbrite.co.uk/e/21st-century-translational-dementia-research-conference-registration-257094766367
